Neutralization of proANP (1-30) exacerbates hypertension in the spontaneously hypertensive rat

Clinical and Experimental Pharmacology and Physiology

Volumn 30, Issue 9, 2003, Pages 627-631

  Dietz, John R ^a,b   Vesely, David L ^a   Gower Jr , William R ^a   Landon, Carol S ^a   Jeong Lee, Sook ^a   Nazian, Stanley J ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Atrial natriuretic peptide; Cardiac hormones; Hypertension; proANP; Volume expansion

Indexed keywords

ALBUMIN; PENTOBARBITAL; PEPTIDE DERIVATIVE; PROATRIAL NATRIURETIC FACTOR[1-30]; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VOLUME; CONTROLLED STUDY; DISEASE EXACERBATION; ESSENTIAL HYPERTENSION; MALE; NONHUMAN; RAT; REGULATORY MECHANISM; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; ANTIBODIES; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; HYPERTENSION; MALE; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; RATS; RATS, INBRED SHR;

EID: 0141595955     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2003.03888.x     Document Type: Article

References (28)

1. Dietz JR. Release of natriuretic factor from rat heart-lung preparation by atrial distension. Am. J. Physiol. 1984; 247: R1093-6.
2. Dietz JR. Control of atrial natriuretic factor release from a rat heart-lung preparation. Am. J. Physiol. 1987; 252: R498-502.
3. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol. Rev. 1990; 70: 665-95.
4. Clinkingbeard C, Sessions C, Shenker Y. The physiological role of atrial natriuretic hormone in the regulation of aldosterone and salt and water metabolism. J. Clin. Endocrinol. Metab. 1990; 70: 582-9.
5. DeBold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981; 28: 89-94.
6. Hirth C, Stasch J-P, John A et al. The renal response to acute hypervolemia is caused by atrial natriuretic peptides. J. Cardiovasc. Pharmacol. 1986; 8: 268-75.
7. Hirth C, Stasch J-P, Kazda S et al. Blockade of the response to volume expansion by monoclonal antibodies against atrial natriuretic peptides. Klin. Wochenschr. 1987; 65: 87-91.
8. Pamnani MB, Mueller GP, Ghai RD, Haddy FJ. Role of atrial natriuretic factor in regulation of blood pressure in normotensive rats having reduced renal mass. Proc. Soc. Exp. Biol. Med. 1988; 189: 297-303.
9. Field LJ, Veress AT, Steinhelper ME, Cochrane K, Sonnenberg H. Kidney function in anf transgenic mice: Effect of blood volume expansion. Am. J. Physiol. 1991; 260: R1-5.
10. John SWM, Krege JH, Oliver PM et al. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 1995; 267: 679-81.
11. Klinger JR, Warburton RR, Pietras LA, Swift R, John S, Hill NS. Exaggerated pulmonary hypertensive responses during chronic hypoxia in mice with gene-targeted reductions in atrial natriuretic peptide. Chest 1998; 114 (Suppl. 1): S79-80.
12. Sarzaani R, Dessi-Fulgheri P, Salvi F et al. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hpertensives. J. Hypertens. 1999; 17: 1301-5.
13. Lin K-F, Chao J, Chao L. Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats. Hum. Gene Ther. 1998; 9: 1429-38.
14. Ruskoaho H. Atrial natriuretic peptide: Synthesis, release and metabolism. Pharmacol. Rev. 1992; 44: 479-602.
15. Dietz JR, Nazian SJ, Vesely DL. Release of ANF, ProANF 1-98, and ProANF 31-67 from isolated rat atria by atrial distension. Am. J. Physiol. 1991; 260: H1774-8.
16. Dietz JR, Gower WR, Vesely DL, Nazian SJ, Landon CS, Skvorak JP. Molecular species of the atrial natriuretic peptide (ANP) prohormone secreted by isolated rat atria. In: Vesely DL (ed.). Atrial Natriuretic Peptides. Research Signpost, Trivandrum. 1997; 119-27.
17. Winters CJ, Sallman AL, Baker BJ, Meadows J, Rico DM, Vesely DL. The N-terminus and a 4000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure. Circulation 1989; 80: 438-49.
18. Vesely DL, Douglass MA, Dietz JR et al. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans. Circulation 1994; 90: 1129-40.
19. 2-terminus are natriuretic and/ for kaliuretic. Am. J. Physiol. 1990; 258: F1401-8.
20. Dietz JR, Vesely DL, Gower J, William R, Nazian SJ. Secretion and renal effects of ANF prohormone peptides. Clin. Exp. Pharmacol. Physiol. 1995; 22: 115-20.
21. Dietz JR, Scott DY, Landon CS, Nazian SJ. Evidence supporting a physiological role for proANP-(1-30) in the regulation of renal excretion. Am. J. Physiol. 2001; 280: R1510-17.
22. Dietz JR, Vesely DL, Nazian SJ. Effect of changes in sodium intake on atrial natriuretic factor (ANF) and peptides derived from the N terminus of the ANF prohormone in the rat (43392). Proc. Soc. Exp. Biol. Med. 1992; 200: 44-8.
23. Ramirez G, Saba SR, Dietz JR, Vesely DL. Immunocytochemical localization of proANF 1-30, proANF 31-67, and atrial natriuretic factor on the kidney. Kidney Int. 1992; 41: 334-41.
24. Weir ML, Honrath U, Flynn TG, Sonnenberg H. Lack of biologic activity or specific binding of amino-terminal pro-ANP segments in the rat. Regul. Pept. 1994; 53: 111-22.
25. Vesely DL, Norris JS, Walters JM, Jespersen RR, Baeyens DA. Atrial natriuretic prohormone peptides 1-30, 31-67, and 79-98 vasodilate the aorta. Biochem. Biophys. Res. Commun. 1987; 148: 1540-8.
26. Dietz JR, Vesley DL, Nazian SJ. Possible mechanisms involved in the natriuretic response to atrial natriuretic factor (ANF) and proANF 31-67 in the rat. Clin. Exp. Pharmacol. Physiol. 1994; 21: 599-606.
27. + transport in rabbit inner medullary collecting duct cells. Role of prostaglandin E2. J. Clin. Invest. 1992; 89: 1411-17.
28. +-ATPase of the atrial natriuretic peptides. Endocrinology 1995; 136: 2033-9.